Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer

This study is currently recruiting participants.
Verified August 2012 by Queen's Medical Centre
Sponsor:
Collaborator:
National Cancer Institute (funding source)
Information provided by (Responsible Party):
Sandi Kwee, Queen's Medical Centre
ClinicalTrials.gov Identifier:
NCT00928252
First received: June 24, 2009
Last updated: August 1, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2013
  Estimated Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)